REFRACTORY MELANOMA

Clinical trials for REFRACTORY MELANOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MELANOMA trials appear

Sign up with your email to follow new studies for REFRACTORY MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 5 Terminated 1

Experimental melanoma combo trial shutters after just one patient

Disease control Terminated

This phase II trial tested a mix of a personalized dendritic cell vaccine and three immune-boosting drugs in people with advanced melanoma that no longer responded to PD-1/PD-L1 checkpoint inhibitors. The goal was to see if the combination could shrink tumors or slow their growth…

Matched conditions: REFRACTORY MELANOMA

Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC

REFRACTORY MELANOMA

Get alerted when new REFRACTORY MELANOMA trials appear

Experimental melanoma combo trial shutters after just one patient